Chest pain secondary prevention

Jump to navigation Jump to search

Chest pain Microchapters


Patient Information


Historical Perspective




Differentiating Chest pain from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis

Chest Pain in Pregnancy


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings



Echocardiography and Ultrasound

CT scan


Other Imaging Findings

Other Diagnostic Studies


Medical Therapy



Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chest pain secondary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides


Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chest pain secondary prevention

CDC on Chest pain secondary prevention

Chest pain secondary prevention in the news

Blogs on Chest pain secondary prevention

to Hospitals Treating Chest pain secondary prevention

Risk calculators and risk factors for Chest pain secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2] Nuha Al-Howthi, MD[3]


Secondary prevention of chest pain depends on the cause for instance, risk factor modification remains essential part of the secondary prevention strategy in chronic stable angina. Secondary prevention of chest pain caused by GERD is avoiding food that worsens the symptoms, smoking cessation, weight loss, eating frequent meals, and head raising of the bed while sleeping.

Secondary Prevention

Secondary prevention of chest pain depend on the cause:

  • Secondary prevention of chest pain due to chronic stable angina, risk factor modification remains an urgent and essential part of secondary prevention strategy. ACC/AHA states that Identifying and, when present, treating Category I risk factors can be an optimal secondary prevention strategy in patients with chronic stable angina. You can read more about general coronary heart disease secondary prevention, here.

You can read in greater detail about each of the risk factor modification topic below by clicking on the link for that topic:


  1. Caforio, A. L. P.; Pankuweit, S.; Arbustini, E.; Basso, C.; Gimeno-Blanes, J.; Felix, S. B.; Fu, M.; Helio, T.; Heymans, S.; Jahns, R.; Klingel, K.; Linhart, A.; Maisch, B.; McKenna, W.; Mogensen, J.; Pinto, Y. M.; Ristic, A.; Schultheiss, H.-P.; Seggewiss, H.; Tavazzi, L.; Thiene, G.; Yilmaz, A.; Charron, P.; Elliott, P. M. (2013). "Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases". European Heart Journal. 34 (33): 2636–2648. doi:10.1093/eurheartj/eht210. ISSN 0195-668X.
  2. C. L. Miklozek, E. M. Kingsley, C. S. Crumpaker, J. F. Modlin, H. D. Royal, P. C. Come, R. Mark & W. H. Abelmann (1986). "Serial cardiac function tests in myocarditis". Postgraduate medical journal. 62 (728): 577–579. doi:10.1136/pgmj.62.728.577. PMID 3774697. Unknown parameter |month= ignored (help)
  3. DeVault KR, Castell DO, American College of Gastroenterology (2005). "Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease". Am J Gastroenterol. 100 (1): 190–200. doi:10.1111/j.1572-0241.2005.41217.x. PMID 15654800.
  4. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(RR-4):1–28. PMID 10366138.

Template:WH Template:WS